Borderline Personality Disorder, An Issue of Psychiatric Clinics of North America
Borderline Personality Disorder, An Issue of Psychiatric Clinics of North America
YOU SAVE £9.33
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
- More about Borderline Personality Disorder, An Issue of Psychiatric Clinics of North America
This issue of Psychiatric Clinics of North America, edited by Drs. Frank Yeomans and Kenneth Levy, will offer a comprehensive review of key topics in Borderline Personality Disorder, led by Dr. Harsh Trivedi. It will explore conceptual models, diagnosis, assessment, comorbidity, longitudinal course, neuroscience, social cognition, attachment, psychotherapy, and family and patient perspectives.
\n Format: Hardback
\n \n Publication date: 20 December 2018
\n Publisher: Elsevier - Health Sciences Division
\n
The upcoming issue of Psychiatric Clinics of North America, meticulously edited by Drs. Frank Yeomans and Kenneth Levy, presents a comprehensive exploration of vital topics related to Borderline Personality Disorder (BPD). Under the guidance of our Consulting Editor, Dr. Harsh Trivedi of Sheppard Pratt Health System, this esteemed series delves into diverse aspects of this complex disorder.
Conceptual Models:
This issue offers a comprehensive review of conceptual models that shed light on the etiology, phenomenology, and treatment of BPD. Experts in the field provide insights into the various frameworks and theories that have contributed to our understanding of this disorder.
Diagnosis and Assessment:
Detailed discussions are conducted on the diagnostic criteria and assessment methods employed in diagnosing BPD. Experts discuss the challenges and nuances involved in accurately identifying individuals with BPD, as well as the importance of comprehensive evaluation to ensure accurate diagnosis and appropriate treatment.
Differential Diagnosis:
A thorough examination of differential diagnosis is conducted, exploring the various conditions that may present with similar symptoms or characteristics. This section helps clinicians differentiate BPD from other mental health disorders and provides guidance in accurate diagnosis and treatment planning.
Community and Clinical Epidemiology:
The impact of BPD on individuals, families, and communities is explored through a comprehensive review of community and clinical epidemiology. Experts examine the prevalence, risk factors, and outcomes associated with BPD, shedding light on the societal and healthcare implications of this disorder.
Comorbidity:
The issue delves into the complex relationship between BPD and other mental health disorders, such as anxiety, depression, substance abuse, and trauma. Experts discuss the co-occurrence of these conditions and explore the challenges and opportunities for effective treatment and management.
Longitudinal Course:
A longitudinal perspective is provided, examining the course of BPD over time. Experts discuss the patterns of symptoms, treatment response, and the potential for recovery in individuals with BPD. This section offers valuable insights into the long-term management and treatment of BPD.
Neuroscience and Social Cognition:
The role of neuroscience and social cognition in understanding the mechanisms underlying BPD is explored. Experts discuss the neurobiological underpinnings of emotional dysregulation, impulsivity, and the development of maladaptive coping strategies in individuals with BPD. This section highlights the potential for innovative treatment approaches that leverage neuroscientific knowledge.
Attachment:
Attachment theory plays a significant role in understanding the relationship dynamics and emotional regulation issues associated with BPD. Experts discuss the attachment patterns of individuals with BPD, the impact of attachment insecurity on their behavior, and the importance of attachment-based therapies in promoting healing and recovery.
Psychotherapy and Medication Treatment Research:
The issue provides a comprehensive review of psychotherapy and medication treatment research in BPD. Experts discuss the effectiveness of various therapeutic approaches, such as cognitive-behavioral therapy, dialectical behavior therapy, and psychodynamic therapy. Additionally, the latest research findings on medication treatment options, including antidepressants, mood stabilizers, and antipsychotics, are discussed.
Psychotherapy with Children and Adolescents:
Special attention is given to the treatment of BPD in children and adolescents. Experts discuss the unique challenges and considerations in working with this population, including the development of effective interventions and strategies tailored to their age and developmental needs.
Family and Patient Perspectives:
The issue includes perspectives from individuals with BPD, their families, and healthcare professionals. These narratives provide valuable insights into the experiences of those living with BPD, the impact of the disorder on their lives, and the importance of family-oriented treatment approaches.
In conclusion, the upcoming issue of Psychiatric Clinics of North America, under the guidance of Drs. Frank Yeomans and Kenneth Levy, presents a comprehensive and insightful exploration of Borderline Personality Disorder. With a focus on conceptual models, diagnosis and assessment, differential diagnosis, community and clinical epidemiology, comorbidity, longitudinal course, neuroscience and social cognition, attachment, psychotherapy and medication treatment research, psychotherapy with children and adolescents, and family and patient perspectives, this issue aims to advance our understanding of this complex disorder and provide valuable guidance for clinicians and researchers.
\n Weight: 500g\n
Dimension: 161 x 236 x 13 (mm)\n
ISBN-13: 9780323642132\n \n
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.